| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Hepion Pharmaceuticals Inc (STU: 336P)
336P Technical Analysis
5
| As on 24th May 2023 336P SHARE Price closed @ 9.32 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1.15 & Strong Buy for SHORT-TERM with Stoploss of 1.51 we also expect STOCK to react on Following IMPORTANT LEVELS. |
336PSHARE Price
| Open | 9.32 | Change | Price | % |
| High | 9.32 | 1 Day | 8.85 | 1882.98 |
| Low | 9.32 | 1 Week | 0.00 | 0.00 |
| Close | 9.32 | 1 Month | 8.71 | 1427.87 |
| Volume | N/A | 1 Year | 7.99 | 600.75 |
| 52 Week High 11.58 | 52 Week Low 0.24 | ||||
STU Germany Most Active Stocks
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| TINC | 0.01 | -1.50% |
| PGF | 19.13 | -90.20% |
| PGF | 19.13 | -90.20% |
| DMJ | 0.17 | 6.25% |
| DMJ | 0.17 | 6.25% |
STU Germany Top Gainers Stocks
STU Germany Top Losers Stocks
| 336P Daily Charts |
336P Intraday Charts |
Whats New @ Bazaartrend |
336P Free Analysis |
|
|
336P Important Levels Intraday
| RESISTANCE | 9.32 |
| RESISTANCE | 9.32 |
| RESISTANCE | 9.32 |
| RESISTANCE | 9.32 |
| RESISTANCE | 9.32 |
| RESISTANCE | 9.32 |
| RESISTANCE | 9.32 |
| RESISTANCE | 9.32 |
336P Forecast April 2024
| 4th UP Forecast | 10.4 |
| 3rd UP Forecast | 10.05 |
| 2nd UP Forecast | 9.84 |
| 1st UP Forecast | 9.63 |
| 1st DOWN Forecast | 9.01 |
| 2nd DOWN Forecast | 8.8 |
| 3rd DOWN Forecast | 8.59 |
| 4th DOWN Forecast | 8.24 |
336P Weekly Forecast
| 4th UP Forecast | 9.55 |
| 3rd UP Forecast | 9.48 |
| 2nd UP Forecast | 9.43 |
| 1st UP Forecast | 9.39 |
| 1st DOWN Forecast | 9.25 |
| 2nd DOWN Forecast | 9.21 |
| 3rd DOWN Forecast | 9.16 |
| 4th DOWN Forecast | 9.09 |
336P Forecast2024
| 4th UP Forecast | 31.52 |
| 3rd UP Forecast | 24.4 |
| 2nd UP Forecast | 20 |
| 1st UP Forecast | 15.6 |
| 1st DOWN Forecast | 3.04 |
| 2nd DOWN Forecast | -1.36 |
| 3rd DOWN Forecast | -5.76 |
| 4th DOWN Forecast | -12.88 |
Hepion Pharmaceuticals Inc ( STU Germany Symbol : 336P )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
336P Business Profile
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing CRV431, a cyclophilin inhibitor that is in Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey. Address: 399 Thornall Street, Edison, NJ, United States, 08837
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service